Azurrx Biopharma Inc (AZRX) Stock Analyst Ratings
USA - NASDAQ:AZRX -
3.45
+0.07 (+2.07%)
3.42
-0.03 (-0.87%)
ChartMill assigns a Buy % Consensus number of 90% to AZRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.4. This target is -1.45% below the current price.
AZRX was analyzed by 4 analysts. The buy percentage consensus is at 90. So analysts seem to be very confident about AZRX.
In the previous month the buy percentage consensus was at a similar level.
Only 4 analysts analyzed AZRX. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-08-02 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-01 | Roth Capital | Maintains | Buy |
| 2021-04-01 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-10 | HC Wainwright & Co. | Maintains | Buy |
Azurrx Biopharma Inc / AZRX FAQ
Can you provide the average price target for Azurrx Biopharma Inc stock?
4 analysts have analysed AZRX and the average price target is 3.4 null. This implies a price decrease of -1.45% is expected in the next year compared to the current price of 3.45.
What is the consensus rating for AZRX stock?
The consensus rating for Azurrx Biopharma Inc (AZRX) is 90 / 100 . This indicates that analysts generally have a positive outlook on the stock.